MENZO, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 3.820
EU - Europa 1.822
AS - Asia 308
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 2
OC - Oceania 2
SA - Sud America 2
Totale 5.963
Nazione #
US - Stati Uniti d'America 3.815
UA - Ucraina 461
IT - Italia 290
IE - Irlanda 272
DE - Germania 222
SE - Svezia 194
DK - Danimarca 171
FI - Finlandia 103
TR - Turchia 97
SG - Singapore 95
KR - Corea 89
GB - Regno Unito 72
CN - Cina 17
BE - Belgio 16
FR - Francia 12
IN - India 8
CA - Canada 5
EU - Europa 5
A1 - Anonimo 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
JP - Giappone 2
PL - Polonia 2
PY - Paraguay 2
RO - Romania 2
AU - Australia 1
HR - Croazia 1
HU - Ungheria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 5.963
Città #
Jacksonville 479
Chandler 441
Fairfield 376
Des Moines 301
Dublin 272
Ashburn 235
Wilmington 189
Woodbridge 165
Houston 153
Seattle 139
Boardman 129
Ann Arbor 119
New York 115
Lawrence 107
Princeton 107
San Mateo 107
Cambridge 100
Redmond 70
San Diego 52
Civitanova Marche 38
Centro 35
London 23
Turin 19
Brussels 16
Marche 16
Helsinki 14
Washington 12
Appignano 11
Beijing 11
Norwalk 10
Hanover 9
Los Angeles 9
Ancona 7
Chicago 7
Cingoli 7
Falls Church 7
Pune 7
Monte San Pietrangeli 6
Rome 6
Bari 5
Cagliari 4
Fano 4
Kilburn 4
Milan 4
Ottawa 4
Chiswick 3
Pesaro 3
Senigallia 3
Tappahannock 3
Abidjan 2
Arco 2
Asunción 2
Bologna 2
Caserta 2
Cava De' Tirreni 2
Dugenta 2
Hounslow 2
Köseköy 2
Macerata 2
New Bedfont 2
Porto 2
Southend 2
Stillwater 2
Tolentino 2
Torre Annunziata 2
Weihai 2
Acton 1
Andover 1
Angri 1
Auburn Hills 1
Auckland 1
Belgrade 1
Belvedere Spinello 1
Birmingham 1
Boston 1
Budapest 1
Cantu 1
Casale Monferrato 1
Castelfranco Emilia 1
Chengdu 1
Copenhagen 1
Corinaldo 1
Delhi 1
Denver 1
Fayetteville 1
Florence 1
Formigine 1
Frankfurt am Main 1
Galati 1
Genova 1
Hendon 1
Hunedoara 1
Izmir 1
Jesi 1
Jiaxing 1
Las Vegas 1
Lecco 1
Lexington 1
Marseille 1
Melbourne 1
Totale 4.031
Nome #
Antimicrobial Resistance: A Challenge for the Future 143
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing 105
A clone of linezolid-resistant Staphylococcus epidermidis bearing the G2576T mutation is endemic in an Italian hospital 100
Competitive polymerase chain reaction and analysis of viral activity at the molecular level. 96
Hepatitis E in a region of Italy: An emerging autochthonous infection? 95
Increase and diversity of carbapenemase-producing Escherichia coli isolates, Italy 92
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. 91
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 88
null 86
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 84
Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. 83
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. 81
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 81
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. 80
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 79
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. 75
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. 74
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. 73
Quantification of the HIV-1 total reservoir in the peripheral blood of naïve and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay. 73
Tocilizumab in COVID-19 interstitial pneumonia 73
Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. 72
A large epidemic of hepatitis B in Serbia: an integrated model for outbreak investigations in healthcare settings 72
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. 71
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types 70
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. 69
Quantitative molecular methods in virology. 68
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan 68
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. 67
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 67
Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. 67
Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. 65
Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation 65
Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002–2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment 63
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. 62
Eritromicino-resistenza da efflusso in ceppi tetraciclino-sensibili (Tcs) e tetraciclino-resistenti (Tcr) di Streptococcus pyogenes. 62
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC 62
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 62
Quantitative PCR and RT-PCR in virology. 61
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 60
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. 60
Analisi della regione tet(O)-mef(A) in un elemento orf3-negativo di Streptococcus pyogenes. 58
Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. 58
Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. 57
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 56
A statistical model based on serological parameters for predicting occult HBV infection: implications for organ/ blood donations 56
Vaginal micropapillary lesions are not related to human papillomavirus infection: in situ hybridization and polymerase chain reaction detection techniques 56
First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid 56
Long-term follow-up of acute hepatitis B: New insights in its natural history and implications for antiviral treatment 55
Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic. 53
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment. 53
null 53
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. 52
Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants 52
Human papillomavirus infections: new perspectives for prevention and treatment. 51
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 51
Cluster analysis of antibiotic susceptibility patterns of clinical isolates as a tool in nosocomial infection surveillance. 51
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 (HIV-1) infection 50
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy. 50
42. Adenoviridae 50
Italian Patent with european extension: New molecular vector for the geno-phenotypic characteristics of V3 sequences of the HIV gp120. 50
Molecular epidemiology and pathogenetic potential of underdiagnosed human papillomavirus types. 50
A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. 49
Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function. 48
Comparison of HIV-1 recombinant phenotypic assays and virtual phenotype in the definition of coreceptor usage 47
Clearance of HIV-1 viraemia after seroconversion. 47
Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. 46
Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy. 46
Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis). 45
Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects. 45
PCR real time assays for the early detection of BKV-DNA in immunocompromised patients. 44
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands. 44
HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system 43
Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO. 43
Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus. 43
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy. 43
European Patent n° EPO 99830776.3: Method to evaluate the HIV drug sensitivity 43
Simple and reliable method to quantify the hepatitis B viral load and replicative capacity in liver tissue and blood leukocytes 43
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT. 43
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). 42
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. 41
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. 41
Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. 41
Detection of human immunodeficiency virus type 1 transcripts in peripheral blood lymphocytes by the polymerase chain reaction. 41
Direct detection of HBV preC mutants in heterogeneous viral populations by a modified DNA sequencing method. 41
Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro. 40
Quantitation of hepatitis C virus genome molecules in plasma samples. 40
Hepatitis B virus preC mutants in human hepatocellular carcinoma tissues. 39
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds 39
SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor 38
Lack of Chlamydia infection of the central nervous system in multiple sclerosis. 38
Lack of detectable human T-cell lymphotropic virus type I sequences in samples from multiple sclerosis patients. 38
Hemagglutinin 222 variants in pandemic (H1N1) 2009 virus. 38
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 37
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 36
The introduction of the fusion inhibitors in the HAART-regimens. 35
No evidence of association between Borrelia Burgdorferi and primary cutaneous B-cell lymphomas in Marche Region, in Italy. 35
Insulin-like growth factor 1 (IGF-1) expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab-irinotecan. 35
Comparison of levels of HIV-1 resistance to protease inhibitors by recombinant versus conventional virus phenotypic assay and two genotypic interpretation procedures in treatment-naive and HAART-experienced HIV-infected patients. 34
The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining 34
Immune response, rather than sensitivity to entecavir, may determine the rate of viral decay upon treatment initiation in patients with chronic HBV infection 32
Totale 5.780
Categoria #
all - tutte 30.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 4 9 9
2019/2020617 7 2 107 5 102 3 110 8 98 22 21 132
2020/20211.504 81 196 251 24 147 86 134 110 139 123 150 63
2021/2022882 83 211 13 24 10 53 56 58 67 58 68 181
2022/20231.545 136 116 124 113 117 393 10 72 330 6 99 29
2023/2024714 134 16 50 118 167 151 8 40 15 15 0 0
Totale 6.052